PRDX1 and non-small cell lung carcinoma: PRDX1 promotes cell proliferation by activating Wnt–β-catenin signalling and is an independent prognostic factor for disease recurrence and reduced survival in patients with non-small-cell lung carcinoma (Song et al., 2023).